These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37407397)

  • 21. In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.
    Rehnström Loi U; Prata N; Grossman A; Lavelanet A; Williams N; Ganatra B
    Reprod Health; 2023 Jan; 20(Suppl 1):20. PubMed ID: 36694182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.
    Newhall EP; Winikoff B
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S44-53. PubMed ID: 10944369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
    Neill S; Hoe E; Fortin J; Goldberg AB; Janiak E
    Contraception; 2023 Oct; 126():110108. PubMed ID: 37394110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of self-assessment of gestational duration among people seeking abortion.
    Ralph LJ; Ehrenreich K; Barar R; Biggs MA; Morris N; Blanchard K; Kapp N; Moayedi G; Perritt J; Raymond EG; White K; Grossman D
    Am J Obstet Gynecol; 2022 May; 226(5):710.e1-710.e21. PubMed ID: 34922922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety, Efficacy and Acceptability of Early First Trimester Abortion using Oral Mifepristone and Sublingual Misoprostol.
    Shrestha D; Aryal S; Sharma B
    J Nepal Health Res Counc; 2018 Oct; 16(3):269-273. PubMed ID: 30455484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
    Ngoc NTN; Shochet T; Raghavan S; Blum J; Nga NTB; Minh NTH; Phan VQ; Winikoff B
    Obstet Gynecol; 2011 Sep; 118(3):601-608. PubMed ID: 21860289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.
    Durocher J; Kilfedder C; Frye LJ; Winikoff B; Srinivasan K
    Sex Reprod Health Matters; 2021 Dec; 29(1):1982460. PubMed ID: 34719353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Gilbert AL; Gelfand D; Fortin J; Roncari D; Goldberg AB
    Contraception; 2023 Apr; 120():109955. PubMed ID: 36634731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
    Tamang A; Puri M; Lama K; Shrestha P
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion.
    Baker CN
    J Health Polit Policy Law; 2023 Aug; 48(4):485-510. PubMed ID: 36693178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second- and Third-Trimester Medical Abortion Providers and Services in 2019: Results From the Canadian Abortion Provider Survey.
    Renner R; Ennis M; Guilbert E; Roy G; Barrett J
    J Obstet Gynaecol Can; 2022 Jun; 44(6):690-699. PubMed ID: 35183788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making the case for advance provision of mifepristone and misoprostol for abortion in the United States.
    Ehrenreich K; Biggs MA; Grossman D
    BMJ Sex Reprod Health; 2022 Oct; 48(4):238-242. PubMed ID: 34862207
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous compared to interval administration of mifepristone and misoprostol for medical abortion up to 10
    Schmidt-Hansen M; Lord J; Hasler E; Cameron S
    BMJ Sex Reprod Health; 2020 Oct; 46(4):270-278. PubMed ID: 32079651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study.
    Blanchard K; Lince-Deroche N; Fetters T; Devjee J; de Menezes ID; Trueman K; Sudhinaraset M; Nkonko E; Moodley J
    Contraception; 2015 Oct; 92(4):330-8. PubMed ID: 26162575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating self-managed medication abortion with medical care.
    Dragoman M; Fofie C; Bergen S; Chavkin W
    Contraception; 2022 Apr; 108():1-3. PubMed ID: 34971608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study.
    Dunn S; Munro S; Devane C; Guilbert E; Jeong D; Stroulia E; Soon JA; Norman WV
    J Med Internet Res; 2022 May; 24(5):e34302. PubMed ID: 35511226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
    Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
    Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers and Facilitators to the Implementation of First Trimester Medical Abortion With Mifepristone in the Province of Québec: A Qualitative Investigation.
    Wagner MS; Munro S; Wilcox ES; Devane C; Norman WV; Dunn S; Soon JA; Guilbert É
    J Obstet Gynaecol Can; 2020 May; 42(5):576-582. PubMed ID: 31924442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.